VDR rs7832551: Muscle Strength & Fitness Genetics
The rs7832551 variant is a single nucleotide polymorphism located within the vitamin D receptor (VDR) gene on chromosome 12. Variations in this genomic region have been investigated for their potential role in modulating vitamin D signaling in skeletal muscle tissue, with candidate-gene studies exploring associations with muscle strength, grip performance, and lean muscle mass preservation. However, the evidence supporting these specific fitness associations remains limited, and lifestyle factors like progressive resistance exercise and nutrition continue to play the primary role in muscular adaptation.
What each genotype means
Typical Muscle Strength Profile
You carry two copies of the C allele at rs7832551 in the VDR gene. Published candidate-gene studies suggest this baseline genotype is associated with typical age-related muscle maintenance and standard muscle strength response. However, overall evidence across diverse populations remains limited and subject to environmental factors like vitamin D status and physical training.
Carried by approximately 35% to 40% of individuals of European ancestry, with variable frequencies across other ancestral populations.
Intermediate Strength Association
You carry one copy of the T allele and one copy of the C allele at rs7832551 in the VDR gene. Having one T allele has been nominally associated in limited research with subtle differences in muscle grip strength and physical performance parameters. Because scientific evidence is preliminary and varies by ancestry and lifestyle, this genotype does not determine physical fitness on its own.
Carried by roughly 45% to 50% of people of European ancestry, representing the most common genotype in many cohorts.
Potential Muscle Strength Variation
You carry two copies of the T allele at rs7832551 in the VDR gene. Some limited research suggests individuals with this genotype may exhibit minor differences in muscle mass preservation and grip strength, especially in interaction with circulating vitamin D levels. However, these associations stem from limited observational studies and should not be viewed as predictive of athletic ability or muscle disease.
Carried by approximately 15% to 20% of people of European ancestry; frequency varies widely among global populations.
What Is rs7832551 and Where Is It Located?
The single nucleotide polymorphism rs7832551 is a common genetic marker mapped to human chromosome 12, falling within the genomic boundaries of the VDR (vitamin D receptor) gene. At this specific position, individuals inherit either an adenine (A) or guanine (G) nucleotide from each parent, creating three possible diploid genotypes: AA, AG, or GG. In genetic studies, rs7832551 is often evaluated either directly or as part of larger haplotype blocks that include other well-known VDR markers such as FokI, BsmI, and ApaI. Because rs7832551 is situated in a non-coding region of the VDR locus, it does not alter the underlying amino acid sequence of the receptor directly. Instead, researchers hypothesize that such non-coding variants may subtly influence gene transcription efficiency, mRNA stability, or local chromatin structure, thereby subtly modifying how efficiently the body translates vitamin D signaling cues into downstream cellular actions.
The Biological Role of the Vitamin D Receptor
The VDR gene encodes a ligand-dependent nuclear transcription factor that mediates the genomic and rapid non-genomic actions of active vitamin D (1,25-dihydroxyvitamin D3). While historically appreciated primarily for regulating calcium homeostasis and bone mineralization, VDR is expressed across numerous tissues, including skeletal muscle fibers. Upon activation, the receptor forms a heterodimer with the retinoid X receptor (RXR), binds specific vitamin D response elements in genomic DNA, and coordinates the transcription of target genes. In myocytes, intact vitamin D signaling supports muscle protein synthesis through downstream pathways such as mTORC1, modulates intracellular calcium fluxes necessary for muscular contraction, and influences muscle fiber composition. Disruption or variations in this receptor system can alter how muscle tissue responds to systemic vitamin D availability, providing a plausible biological framework for why genetic variations in the VDR locus have become popular candidates in exercise physiology research.
Research on Muscle Strength and Lean Mass
Candidate gene studies have repeatedly explored whether VDR polymorphisms correlate with physical performance phenotypes such as handgrip strength, quadriceps force, and lean muscle mass preservation. Research groups examining skeletal muscle traits across aging adults and athletes have observed modest correlations between VDR genotypes and neuromuscular performance parameters, including risk factors for age-related sarcopenia. Some fitness association reports have proposed that carriers of specific alleles maintain greater muscle mass or exhibit subtle advantages in strength retention. However, the overall scientific evidence linking rs7832551 directly to functional muscular differences is classified as limited. Replications across independent, large-scale cohorts have frequently yielded mixed or conflicting results, often demonstrating negligible effect sizes once rigorous statistical corrections are applied. Furthermore, these associations frequently interact with confounding variables such as baseline circulating 25-hydroxyvitamin D concentrations, training status, and biological sex.
Population Distribution and Ancestry Patterns
The rs7832551 polymorphism is a common variant observed at appreciable frequencies across global human populations. In European reference cohorts, the minor allele frequency is approximately 0.41, meaning both the major and minor alleles are widely distributed and frequently encountered in heterozygous and homozygous forms. Allele distributions can fluctuate across continental ancestries, a common feature of genomic variation within the VDR region shaped by historical human migration and adaptive pressures related to sunlight exposure and bone metabolism. Because genetic background and linkage disequilibrium patterns differ substantially among ancestries, an association reported between rs7832551 and a physical trait in one ethnic group may not translate directly to individuals of different ancestral backgrounds. These frequency variations highlight why population-specific context is critical when interpreting common fitness-related candidate markers.
Practical Implications: What This Genotype Means for You
Finding out your rs7832551 genotype provides insight into your unique genetic variation, but it cannot predict your athletic ability, muscular strength, or risk for muscle loss on its own. Musculoskeletal performance and body composition are highly complex, polygenic phenotypes governed by thousands of interacting genetic loci, each exerting only a minuscule individual effect. More importantly, environmental and behavioral factors exert vastly more influence over muscular adaptation than any single candidate SNP. Progressive resistance training, adequate dietary protein intake, and maintaining clinical vitamin D sufficiency remain the evidence-based pillars of muscle health regardless of genetic status. Consumers should not interpret genotype results as a diagnostic measure or change medical therapies or supplementation regimens without guidance from a qualified physician, sports dietitian, or healthcare professional.
How common is this variant?
The rs7832551 variant is a common single nucleotide polymorphism with a minor allele frequency of approximately 0.41 in European populations. Frequencies of the alternate alleles vary moderately across distinct global ancestral backgrounds according to public population datasets.
Frequently asked questions
Does my rs7832551 genotype determine how strong I can get?
No, your rs7832551 genotype does not determine your maximal strength or athletic capacity. Muscular strength is a complex polygenic trait influenced by thousands of genetic variants alongside training consistency, progressive overload, sleep, and nutrition. A single SNP within the VDR gene has an extremely small effect on overall performance.
Does having a specific VDR genotype mean I need to take vitamin D supplements?
A genetic variation at rs7832551 does not indicate whether you need vitamin D supplementation. Nutritional decisions should be based on objective laboratory testing of serum 25-hydroxyvitamin D levels and personalized advice from your physician or dietitian. Do not self-prescribe high-dose supplements based on genetic testing alone.
How strong is the scientific evidence linking rs7832551 to fitness traits?
The evidence connecting rs7832551 to muscular traits is classified as limited. While early candidate gene studies highlighted possible links between VDR variants and grip strength or muscle preservation, larger replication studies have shown mixed or modest results that vary significantly across different populations.
Can rs7832551 diagnose sarcopenia or muscle disorders?
No, rs7832551 is not a diagnostic marker for sarcopenia, muscular dystrophy, or any medical disorder. Sarcopenia is diagnosed clinically using standardized functional evaluations such as grip dynamometry, gait speed, and validated body composition assessments performed by healthcare professionals.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7832551?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VDR
Variant in the promoter region (Cdx2 site) of the vitamin D receptor gene associated with altered intestinal calcium absorption and bone mineral density.
This variant in the Vitamin D receptor gene is associated with susceptibility to Type 1 Diabetes and autoimmune thyroid disease.
Promoter polymorphism (Cdx2) in the VDR gene associated with bone mineral density and vitamin D metabolism.
Common polymorphism (TaqI variant) in the vitamin D receptor affecting mRNA stability and bone mineral density.
Known as the TaqI polymorphism, this variant is located in the 3' UTR of the VDR gene and is associated with altered mRNA stability, influencing vitamin D signaling, cancer cachexia susceptibility, and gastric cancer risk.
Variant in the VDR promoter (Cdx-2 binding site) associated with bone mineral density and calcium absorption efficiency.